| Literature DB >> 34703892 |
Tomoyasu Noguchi1, Yoshinori Shimamoto2, Ken-Ichi Fukuda1.
Abstract
BACKGROUND: Neurovascular compression (NVC) is a well-known cause of trigeminal neuralgia (TN). However, patients with idiopathic TN (ITN) do not have evidence of NVC on magnetic resonance imaging (MRI), and other patients may remain asymptomatic despite evidence of NVC on MRI. This suggests that there may be additional risk factors for TN development other than NVC. Although epidemiological factors, such as age and sex differences, are useful for understanding the pathophysiology of TN, detailed statistics for each TN subtype are currently unavailable. Therefore, this study aimed to classify patients with TN into the following groups based on data extracted from past medical records: classical TN (CTN), secondary TN, and ITN.Entities:
Keywords: Classical Trigeminal Neuralgia; Idiopathic Trigeminal Neuralgia; Neurovascular Compression; Secondary Trigeminal Neuralgia
Year: 2021 PMID: 34703892 PMCID: PMC8520837 DOI: 10.17245/jdapm.2021.21.5.431
Source DB: PubMed Journal: J Dent Anesth Pain Med ISSN: 2383-9309
Fig. 1(A) Typical example of classical trigeminal neuralgia. The superior cerebellar artery (SCA) is compressing the trigeminal nerve. Arrow: Trigeminal nerve, Arrowhead: SCA (B) Typical example of secondary trigeminal neuralgia. This figure presents a case of trigeminal neuralgia due to a brain tumor. Arrow: Brain tumor compressing the trigeminal nerve.
Comparison of ages between men and women according to each TN subtype, and according to age difference, between CTN and ITN
| CTN | STN | ITN | All TN | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Women | Men | Total | Women | Men | Total | Women | Men | Total | Women | Men | |
| n | 96 | 64 | 32 | 5 | 3 | 2 | 25 | 10 | 15 | 126 | 77 | 49 |
| Mean (±SD) | 61.4(15.5) | 64.4(15.6) | 55.5(13.8) | 59.6(12.8) | 55.3(14.6) | 66.0(9.9) | 56.7(17.8) | 59.5(17) | 52.4(19.1) | 60.4(15.9) | 63.2(15.8) | 55.3(15) |
| Median (IQR) | 64.0(24.3) | 69.0(22.3) | 50.5(20.3) | 59(23) | 49.0(13.5) | 66(7) | 57(33) | 62(26.5) | 49(31.8) | 62(25.8) | 66.5(22.8) | 55(21.8) |
| P value | 0.003* | 0.279 | 0.004* | |||||||||
*Significant difference in the Mann-Whitney U test. CTN, classical trigeminal neuralgia; IQR, interquartile range; ITN, idiopathic trigeminal neuralgia; SD, standard deviation; STN, secondary trigeminal neuralgia; TN, trigeminal neuralgia.
There was no age difference between CTN and ITN.
Laterality of pain and distribution across trigeminal nerve divisions
| n (%) | Right | Left | Total |
|---|---|---|---|
| CTN | |||
| V2 | 22 (22.9) | 15 (15.6) | 37 (38.5) |
| V3 | 25 (26) | 12 (12.5) | 37 (38.5) |
| V1 and V2 | 2 (2.1) | 1 (1) | 3 (3.1) |
| V2 and V3 | 13 (13.5) | 6 (6.3) | 19 (19.8) |
| Total | 62 (64.6) | 34 (35.4) | 96 (100) |
| STN | |||
| V2 | 1 (20) | 0 | 1 (20) |
| V3 | 2 (40) | 0 | 2 (40) |
| V1 and V2 | 0 | 0 | 0 |
| V2 and V3 | 1 (20) | 1 (20) | 2 (40) |
| Total | 4 (80) | 1 (20) | 5 (100) |
| ITN | |||
| V2 | 10 (40) | 3 (12) | 13 (52) |
| V3 | 3 (12) | 6 (24) | 9 (36) |
| V1 and V2 | 0 | 0 | 0 |
| V2 and V3 | 2 (8) | 1 (4) | 3 (12) |
| Total | 15 (60) | 10 (40) | 25 (100) |
| All TN | |||
| V2 | 33 (26.2) | 18 (14.3) | 51 (40.5) |
| V3 | 30 (23.8) | 18 (14.3) | 48 (38.1) |
| V1 and V2 | 2 (1.6) | 1 (0.8) | 3 (2.4) |
| V2 and V3 | 16 (12.7) | 8 (6.3) | 24 (19) |
| Total | 81 (64.3) | 45 (35.7) | 126 (100) |
CTN, classical trigeminal neuralgia; ITN, idiopathic trigeminal neuralgia; STN, secondary trigeminal neuralgia; TN, trigeminal neuralgia; V1, ophthalmic division of the trigeminal nerve; V2, maxillary division of the trigeminal nerve; V3, mandibular division of the trigeminal nerve.
Evaluation of NVC and responsible vessels by MRI
| Symptomatic (painful) side | Asymptomatic side | |||||
|---|---|---|---|---|---|---|
| Type of TN | CTN | STN and ITN | CTN | STN | ITN | Total |
| n | 96 | 30 | 96 | 5 | 25 | 126 |
| SCA | 67 | No NVC | 22 | 1 | 2 | 25 |
| AICA | 10 | 2 | 0 | 1 | 3 | |
| PICA | 1 | 0 | 0 | 0 | 0 | |
| BA | 3 | 0 | 0 | 0 | 0 | |
| VA | 2 | 0 | 0 | 0 | 0 | |
| Vein | 13 | 10 | 0 | 1 | 11 | |
| Total NVC | 96 | 34 | 1 | 4 | 39 | |
| NVC (%) | 100 | 35.4 | 20 | 16 | 31 | |
AICA, anterior inferior cerebellar artery; BA, basilar artery; CTN, classical trigeminal neuralgia; ITN, idiopathic trigeminal neuralgia; MRI, magnetic resonance imaging; NVC, neurovascular compression; PICA, posterior inferior cerebellar artery; SCA, superior cerebellar artery; STN, secondary trigeminal neuralgia; TN, trigeminal neuralgia; VA, vertebral artery.
Treatments administered for each TN subtype
| n (%) | CTN | STN | ITN | All TN |
|---|---|---|---|---|
| Pharmacological treatment | 77 (80.2) | 0 | 22 (88) | 99 (78.6) |
| GKS | 6 (6.3) | 1 (20) | 0 | 7 (5.6) |
| MVD | 11 (11.5) | 4 (80) | 0 | 15 (11.9) |
| Follow-up | 1 (1) | 0 | 1 (4) | 2 (1.6) |
| Interruption | 1 (1) | 0 | 2 (8) | 3 (2.4) |
| Total | 96 (100) | 5 (100) | 25 (100) | 126 (100) |
CTN, classical trigeminal neuralgia; GKS, gamma knife surgery; ITN, idiopathic trigeminal neuralgia; MVD, microvascular decompression; STN, secondary trigeminal neuralgia; TN, trigeminal neuralgia.
Side effects of carbamazepine in each group and changes in treatment
| Changes in treatment | |||||||
|---|---|---|---|---|---|---|---|
| n (%) | Carbamazepine decreased | Pregabalin | GKS | MVD | Alcohol block | Total | |
| CTN N=17/77 (22.1%) | |||||||
| Side effects | Allergic rash | 0 | 2 (11.8) | 1 (5.9) | 2 (11.1) | 0 | 5 (29.4) |
| Liver dysfunction | 0 | 3 (17.6) | 1 (5.9) | 0 | 0 | 4 (23.5) | |
| Light-headedness | 0 | 3 (17.6) | 1 (5.9) | 0 | 0 | 4 (23.5) | |
| Drowsiness | 0 | 1 (5.9) | 0 | 0 | 0 | 1 (5.9) | |
| Diminished warfarin action | 2 (11.8) | 0 | 0 | 1 (5.6) | 0 | 3 (17.6) | |
| Total | 2 (11.8) | 9 (52.9) | 3 (17.6) | 3 (17.6) | 0 | 17 (100) | |
| ITN N=6/22 (27.3%) | |||||||
| Side effects | Allergic rash | 0 | 3 (50) | 0 | 0 | 1 (16.7) | 4 (66.7) |
| Liver dysfunction | 0 | 1 (16.7) | 0 | 0 | 0 | 1 (16.7) | |
| Light-headedness | 0 | 0 | 0 | 0 | 0 | 0 | |
| Drowsiness | 0 | 0 | 0 | 0 | 0 | 0 | |
| Diminished warfarin action | 0 | 0 | 0 | 1 (16.7) | 0 | 1 (16.7) | |
| Total | 0 | 4 (66.7) | 0 | 1 (16.7) | 1 (16.7) | 6 (100) | |
| Total N=23/99 (23.2%) | |||||||
| Side effects | Allergic rash | 0 | 5 (21.7) | 1 (4.3) | 2 (8.7) | 1 (4.3) | 9 (39.1) |
| Liver dysfunction | 0 | 4 (17.4) | 1 (4.3) | 0 | 0 | 5 (21.7) | |
| Light-headedness | 0 | 3 (13) | 1 (4.3) | 0 | 0 | 4 (17.4) | |
| Drowsiness | 0 | 1 (4.3) | 0 | 0 | 0 | 1 (4.3) | |
| Diminished warfarin action | 2 (8.7) | 0 | 0 | 2 (8.7) | 0 | 4 (17.4) | |
| Total | 2 (8.7) | 13 (56.5) | 3 (13) | 4 (17.4) | 1 (4.3) | 23 (100) | |
CTN, classical trigeminal neuralgia; GKS, gamma knife surgery; ITN, idiopathic trigeminal neuralgia; MVD, microvascular decompression; STN, secondary trigeminal neuralgia; TN, trigeminal neuralgia.